The mechanism and clinical application of DNA damage repair inhibitors combined with immune checkpoint inhibitors in the treatment of urologic cancer

Urologic cancers such as kidney, bladder, prostate, and uroepithelial cancers have recently become a considerable global health burden, and the response to immunotherapy is limited due to immune escape and immune resistance. Therefore, it is crucial to find appropriate and effective combination ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Deqian, Jiang, Bowen, Wang, Shijin, Wang, Qifei, Wu, Guangzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248030/
https://www.ncbi.nlm.nih.gov/pubmed/37305685
http://dx.doi.org/10.3389/fcell.2023.1200466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248030/
https://www.ncbi.nlm.nih.gov/pubmed/37305685
http://dx.doi.org/10.3389/fcell.2023.1200466

Ejemplares similares